Literature DB >> 6163296

Chemical nature of the first products (nuclei) of the argyrophil staining.

F Gallyas.   

Abstract

In agreement with LIESEGANG (1911) but in disagreement with VOIGT (1957), PARTRIDGE (1957) and WINKELMANN and SCHMIT (1959), the first product in the majority of the traditional argyrophil methods is submicroscopic grains (nuclei) of metallic silver forming in the impregnating bath at the effect of reducing groups of the tissue (argyrophil I reaction). It is the localization pattern of the metallic silver nuclei that determines the distribution of the silver in the final microscopic image, and not the colloid character of the tissue, as stated by VOIGT (1952) and others. In special cases, colloid grains of certain silver compounds (non-metallic silver nuclei) forming with the contribution of the tissue (argyrophil II reaction) in the impregnating bath constitute the basis of the staining. There are argyrophil methods which consist of pretreatments and a physical development but have no impregnation phase. In one part of them, non-metallic silver nuclei forming with the contribution of the tissue (argyrophil II reaction) in the physical developer, in the other part, certain points of the tissue structure with favourable chemical composition, capable of catalyzing the interaction of silver ions and the reducing component of the physical developer (argyrophil III reaction) serve for the initiation of the staining.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6163296     DOI: 10.1016/S0065-1281(80)80019-5

Source DB:  PubMed          Journal:  Acta Histochem        ISSN: 0065-1281            Impact factor:   2.479


  10 in total

1.  Golgi-like demonstration of "dark" neurons with an argyrophil III method for experimental neuropathology.

Authors:  F Gallyas; F H Güldner; G Zoltay; J R Wolff
Journal:  Acta Neuropathol       Date:  1990       Impact factor: 17.088

2.  Kinetics of formation of metallic silver and binding of silver ions by tissue components.

Authors:  F Gallyas
Journal:  Histochemistry       Date:  1979-11

3.  Increased sensitivity in peroxidase immunocytochemistry. A comparative study of a number of peroxidase visualization methods employing a model system.

Authors:  L Scopsi; L I Larsson
Journal:  Histochemistry       Date:  1986

4.  Physico-chemical mechanism of the argyrophil I reaction.

Authors:  F Gallyas
Journal:  Histochemistry       Date:  1982

5.  Physico-chemical mechanism of the argyrophil III reaction.

Authors:  F Gallyas
Journal:  Histochemistry       Date:  1982

6.  Immunohistochemical localization of extravasated serum albumin in the hippocampus of human subjects with partial and generalized epilepsies and epileptiform convulsions.

Authors:  A Mihály; B Bozóky
Journal:  Acta Neuropathol       Date:  1984       Impact factor: 17.088

7.  Oxalate pretreatment and use of a physical developer render the Kossa method selective and sensitive for calcium.

Authors:  F Gallyas; J R Wolff
Journal:  Histochemistry       Date:  1985

8.  Reversibility of neuropathology in Tay-Sachs-related diseases.

Authors:  María-Begoña Cachón-González; Susan Z Wang; Robin Ziegler; Seng H Cheng; Timothy M Cox
Journal:  Hum Mol Genet       Date:  2013-09-20       Impact factor: 6.150

9.  Comparative in vivo assessment of some adverse bioeffects of equidimensional gold and silver nanoparticles and the attenuation of nanosilver's effects with a complex of innocuous bioprotectors.

Authors:  Boris A Katsnelson; Larisa I Privalova; Vladimir B Gurvich; Oleg H Makeyev; Vladimir Ya Shur; Yakov B Beikin; Marina P Sutunkova; Ekaterina P Kireyeva; Ilzira A Minigalieva; Nadezhda V Loginova; Marina S Vasilyeva; Artem V Korotkov; Eugene A Shuman; Larisa A Vlasova; Ekaterina V Shishkina; Anastasia E Tyurnina; Roman V Kozin; Irene E Valamina; Svetlana V Pichugova; Ludmila G Tulakina
Journal:  Int J Mol Sci       Date:  2013-01-25       Impact factor: 5.923

Review 10.  Silver diagnosis in neuropathology: principles, practice and revised interpretation.

Authors:  Toshiki Uchihara
Journal:  Acta Neuropathol       Date:  2007-03-31       Impact factor: 17.088

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.